10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Current approaches in smart nano‐inspired drug delivery: A narrative review

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background and Aim

          The traditional drug delivery approach involves systemic administration of a drug that could be nonspecific in targeting, low on efficacy, and with severe side‐effects. To address such challenges, the field of smart drug delivery has emerged aiming at designing and developing delivery systems that can target specific cells, tissues, and organs and have minimal off‐target side‐effects.

          Methods

          A literature search was done to collate papers and reports about the currently available various strategies for smart nano‐inspired drug delivery. The databases searched were PubMed, Scopus, and Google Scholar. Based on selection criteria, the most pertinent and recent items were included.

          Results

          Smart drug delivery is a cutting‐edge revolutionary intervention in modern medicines to ensure effective and safe administration of therapeutics to target sites. These hold great promise for targeted and controlled delivery of therapeutic agents to improve the efficacy with reduced side‐effects as compared to the conventional drug delivery approaches. Current smart drug delivery approaches include nanoparticles, liposomes, micelles, and hydrogels, each with its own advantages and limitations. The success of these delivery systems lies in engineering and designing them, and optimizing their pharmacokinetics and pharmacodynamics properties.

          Conclusion

          Development of drug delivery systems that can get beyond various physiological and clinical barriers, as observed in conventionally administered chemotherapeutics, has been possible through recent advancements. Using multifunctional targeting methodologies, smart drug delivery tries to localize therapy to the target location, reduces cytotoxicity, and improves the therapeutic index. Rapid advancements in research and development in smart drug delivery provide wider and more promising avenues to guarantee a better healthcare system, improve patient outcomes, and achieve higher levels of effective medical interventions like personalized medicine.

          Related collections

          Most cited references68

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Nano based drug delivery systems: recent developments and future prospects

          Nanomedicine and nano delivery systems are a relatively new but rapidly developing science where materials in the nanoscale range are employed to serve as means of diagnostic tools or to deliver therapeutic agents to specific targeted sites in a controlled manner. Nanotechnology offers multiple benefits in treating chronic human diseases by site-specific, and target-oriented delivery of precise medicines. Recently, there are a number of outstanding applications of the nanomedicine (chemotherapeutic agents, biological agents, immunotherapeutic agents etc.) in the treatment of various diseases. The current review, presents an updated summary of recent advances in the field of nanomedicines and nano based drug delivery systems through comprehensive scrutiny of the discovery and application of nanomaterials in improving both the efficacy of novel and old drugs (e.g., natural products) and selective diagnosis through disease marker molecules. The opportunities and challenges of nanomedicines in drug delivery from synthetic/natural sources to their clinical applications are also discussed. In addition, we have included information regarding the trends and perspectives in nanomedicine area.
            • Record: found
            • Abstract: found
            • Article: not found

            Cancer nanomedicine: progress, challenges and opportunities

            The intrinsic limits of conventional cancer therapies prompted the development and application of various nanotechnologies for more effective and safer cancer treatment, herein referred to as cancer nanomedicine. Considerable technological success has been achieved in this field, but the main obstacles to nanomedicine becoming a
              • Record: found
              • Abstract: found
              • Article: not found

              Nanocarriers as an emerging platform for cancer therapy.

              Nanotechnology has the potential to revolutionize cancer diagnosis and therapy. Advances in protein engineering and materials science have contributed to novel nanoscale targeting approaches that may bring new hope to cancer patients. Several therapeutic nanocarriers have been approved for clinical use. However, to date, there are only a few clinically approved nanocarriers that incorporate molecules to selectively bind and target cancer cells. This review examines some of the approved formulations and discusses the challenges in translating basic research to the clinic. We detail the arsenal of nanocarriers and molecules available for selective tumour targeting, and emphasize the challenges in cancer treatment.

                Author and article information

                Contributors
                ranjank_mohapatra@yahoo.com
                kudrat.chem@ru.ac.bd
                Journal
                Health Sci Rep
                Health Sci Rep
                10.1002/(ISSN)2398-8835
                HSR2
                Health Science Reports
                John Wiley and Sons Inc. (Hoboken )
                2398-8835
                24 April 2024
                April 2024
                : 7
                : 4 ( doiID: 10.1002/hsr2.v7.4 )
                : e2065
                Affiliations
                [ 1 ] Department of Anesthesia and Critical Care Johns Hopkins School of Medicine Baltimore Maryland USA
                [ 2 ] Department of Pharmacology All India Institute of Medical Sciences (AIIMS) Mangalagiri Andhra Pradesh India
                [ 3 ] Department of Microbiology Prathima Institute of Medical Sciences Karimnagar Telangana India
                [ 4 ] School of Biotechnology, Campus‐11 KIIT Deemed‐to‐be‐University Bhubaneswar Odisha India
                [ 5 ] Molecular Diagnostic Laboratory Johns Hopkins Aramco Healthcare Dhahran Saudi Arabia
                [ 6 ] College of Medicine Alfaisal University Riyadh Saudi Arabia
                [ 7 ] Department of Public Health and Nutrition The University of Haripur Haripur Pakistan
                [ 8 ] Department of Chemistry Government College of Engineering Keonjhar Odisha India
                [ 9 ] Department of Chemistry Rajshahi University Rajshahi Bangladesh
                Author notes
                [*] [* ] Correspondence Ranjan K. Mohapatra, Government College of Engineering, Keonjhar 758002, Odisha, India.

                Email: ranjank_mohapatra@ 123456yahoo.com

                Md. Kudrat‐E‐Zahan, Rajshahi University, Rajshahi 6205, Bangladesh.

                Email: kudrat.chem@ 123456ru.ac.bd

                Author information
                http://orcid.org/0000-0002-7197-0448
                http://orcid.org/0000-0002-3896-5831
                http://orcid.org/0000-0001-7623-3343
                Article
                HSR22065
                10.1002/hsr2.2065
                11040566
                38660006
                cf3ca21e-70e8-4a44-947d-ac465c62e371
                © 2024 The Authors. Health Science Reports published by Wiley Periodicals LLC.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

                History
                : 13 November 2023
                : 14 July 2023
                : 11 April 2024
                Page count
                Figures: 2, Tables: 0, Pages: 9, Words: 5999
                Categories
                Narrative Review
                Narrative Review
                Custom metadata
                2.0
                April 2024
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.4.0 mode:remove_FC converted:24.04.2024

                hydrogels,liposomes,micelles,nanoparticles,smart drug delivery,therapeutics

                Comments

                Comment on this article

                Related Documents Log